ViaWealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Buy |
10,956
+925
| +9% | +$63.8K | 0.45% | 66 |
|
|
2025
Q1 | $697K | Buy |
10,031
+1,755
| +21% | +$122K | 0.43% | 74 |
|
|
2024
Q4 | $712K | Buy |
8,276
+415
| +5% | +$35.7K | 0.43% | 72 |
|
|
2024
Q3 | $936K | Buy |
7,861
+25
| +0.3% | +$2.98K | 0.55% | 60 |
|
|
2024
Q2 | $1.12M | Hold |
7,836
| – | – | 0.69% | 40 |
|
|
2024
Q1 | $1.01M | Hold |
7,836
| – | – | 0.63% | 44 |
|
|
2023
Q4 | $811K | Buy |
+7,836
| New | +$811K | 0.56% | 60 |
|